theHeart.org: Lipid and Metabolic news related to heart conditions.

Lipid/Metabolic

Reducing CV Risk: What Add-On Therapies Do You Use?

12 COMMENTS - Jan 27, 2009 15:53 EST

Reducing CV Risk: What Add-On Therapies Do You Use? Click to take the survey and compare answers. The results will help us create future CME programming

Lipid/Metabolic

hsCRP - How Will Recent Statin Trials Impact CV Risk Assessment?

20 COMMENTS - Dec 19, 2008 11:00 EST

How will the results of JUPITER expand the universe of cardiovascular risk evaluation? Join Drs Ballantyne, Ridker, and Chapman as they discuss this important biomarker study and its implication for clinical practice.

Lipid/Metabolic

Combination Therapy for the Management of Mixed Dyslipidemia

28 COMMENTS - Dec 18, 2008 15:20 EST

What's the latest on reducing residual risk? Read Dr Polsani's overview of the latest clinical trial data on management strategies for mixed dyslipidemia. Then watch Drs Davidson, Plutzky, Wierzbicki, Ballantyne and Nesto as they each give their take including reactions to data released at AHA 2008.

Lipid/Metabolic

New Approaches to Reducing Cardiovascular Risk in Patients With Mixed Dyslipidemia

7 COMMENTS - Nov 10, 2008 10:55 EST

How can we better identify patients at risk of developing cardiovascular disease? Drs Davidson, Ginsberg, and Chapman provide the lowdown on strategies to identify and treat patients with mixed dyslipidemia and ensure they achieve all their target lipid levels.

Lipid/Metabolic

Dyslipidemia and type 2 diabetes: Translating clinical trial data into improving outcomes

14 COMMENTS - Jun 9, 2008 17:47 EDT

Join Drs Frank Sacks, Peter Jones and Theodore Mazzone as they discuss how the results of new clinical trials will affect the treatment of mixed dyslipidemia and reduce cardiovascular risk in patients with type 2 diabetes.

CME provider: Medscape.
The Mixed Dyslipidemia clinical theme is supported by an independent educational grant from Abbott Laboratories.

	Yes
	No